FBT

First Trust NYSE Arca Biotechnology Index Fund

Down$136.53
$-0.99
(-0.72%)
As of 12:00:00 AM EDT | 4/18/19  |  Market Closed

FBT Trading Data

Open

$137.85

Low Price

$134.29

High Price

$138.96

Previous Last Price

$137.52

Bid Size

$0 X 0

Ask Size

$0 X 0

FBT Portfolio Data

AUM

$2,879,577,400

Shares

20,950

PE Ratio

20.57

Price / Book Ratio

5.34

Expense Ratio

0.56

Net Asset Value

$137.45

Volume

Volume

299,300

Avg. Volume (YDT)

150,455

Dollar Volume

$36,959,155

Weekly Avg. Volume

193,820

Monthly Avg. Volume

165,055

Quarterly Avg. Volume

142,395

FBT Fund Description

The First Trust NYSE Arca Biotechnology Index Fund is and exchange-traded index fund. The investment objective of the fund is to replicate as closely as possible, before fees and expenses, the price and yield of the NYSE Arca Biotechnology Index. The NYSE Arca Biotechnology Index is an equal dollar weighted index designed to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services. Such processes include, but are not limited to, recombinant DNA technology, molecular biology, genetic engineering, monoclonal antibody-based technology, lipid/liposome technology, and genomics. The index is rebalanced quarterly based on closing prices on the third Friday in January, April, July and October to ensure that each component stock continues to represent approximately equal weight in the index.

FBT Chart

FBT Summary

Fund Family

First Trust Portfolios

Tracks This Index

First Trust NYSE Arca Biotechnology Index Fund

Inception Date

2006-06-19

Asset Class

Equity

Asset Class Size

Biotech

FBT Classification

Region (General)

Global

Region (Specific)

Sector

Health Care

Equity Index

Leveraged Family

FBT Holdings

Top 10 Holdings

Ionis Pharmaceuticals Inc. (IONS)
4.38%
Ultragenyx Pharmaceutical Inc. (RARE)
4.24%
Bio-Techne Corporation (TECH)
4.04%
Charles River Laboratories International Inc. (CRL)
3.91%
ACADIA Pharmaceuticals Inc. (ACAD)
3.87%
Celgene Corporation (CELG)
3.82%
Alexion Pharmaceuticals Inc. (ALXN)
3.76%
bluebird bio Inc. (BLUE)
3.75%
QIAGEN N.V. (QGEN)
3.64%
IQVIA Holdings Inc. (IQV)
3.63%

Total FBT Holdings

Total Holdings: 31

Ionis Pharmaceuticals Inc. (IONS)
4.38%
Ultragenyx Pharmaceutical Inc. (RARE)
4.24%
Bio-Techne Corporation (TECH)
4.04%
Charles River Laboratories International Inc. (CRL)
3.91%
ACADIA Pharmaceuticals Inc. (ACAD)
3.87%
Celgene Corporation (CELG)
3.82%
Alexion Pharmaceuticals Inc. (ALXN)
3.76%
bluebird bio Inc. (BLUE)
3.75%
QIAGEN N.V. (QGEN)
3.64%
IQVIA Holdings Inc. (IQV)
3.63%
Alnylam Pharmaceuticals Inc. (ALNY)
3.57%
Illumina Inc. (ILMN)
3.56%
Agios Pharmaceuticals Inc. (AGIO)
3.52%
Grifols S.A. (ADR) (GRFS)
3.4%
Alkermes Plc (ALKS)
3.39%
Seattle Genetics Inc. (SGEN)
3.36%
Incyte Corporation (INCY)
3.31%
Exelixis Inc. (EXEL)
3.29%
Gilead Sciences Inc. (GILD)
3.19%
Amgen Inc. (AMGN)
3.12%
Neurocrine Biosciences Inc. (NBIX)
3.1%
FibroGen Inc. (FGEN)
3.06%
United Therapeutics Corporation (UTHR)
3.04%
Vertex Pharmaceuticals Incorporated (VRTX)
2.99%
BioMarin Pharmaceutical Inc. (BMRN)
2.95%
Regeneron Pharmaceuticals Inc. (REGN)
2.86%
Intercept Pharmaceuticals Inc. (ICPT)
2.74%
Nektar Therapeutics (NKTR)
2.36%
Biogen Inc. (BIIB)
2.35%
Intrexon Corporation (XON)
1.65%
First Trust NYSE Arca Biotechnology Index Fund (FBT)
0%

FBT Technicals

Alpha

2.26

Beta

1.6

Leverage

Long

Standard Deviation

8.5

FBT Dividends

Dividend Date

2015-09-23

Latest Dividend

0.02

Annual Dividend

0

Annual Dividend Rate

0

Annual Dividend Yield

1.0E-5

FBT Performance

YTD Return

9.93%

1 Year Return

-0.68%

3 Year Return

40.65%

5 Year Return

90.6%

10 Year Return

608.51%

FBT Related Articles